Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an Early and Collegial Consideration of Patients' Vulnerability Comparing to Usual Care. Cluster Randomized Control Study "Mort-A-l'Hôpital 2"

NCT02906462 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT02906462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02906462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an Early and Collegial Consideration of Patients' Vulnerability Comparing to Usual Care. Cluster Randomized Control Study "Mort-A-l'Hôpital 2"
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2013
Completion date
March 31, 2019
Enrollment
1,200 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

incurable disease